SI9300075A - 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2a)pyrimidin-4-ones, pharmaceutical preparations comprising the same and process pro their preparing - Google Patents

3-(1h-tetrazol-5-yl)-4h-pyrido(1,2a)pyrimidin-4-ones, pharmaceutical preparations comprising the same and process pro their preparing Download PDF

Info

Publication number
SI9300075A
SI9300075A SI19939300075A SI9300075A SI9300075A SI 9300075 A SI9300075 A SI 9300075A SI 19939300075 A SI19939300075 A SI 19939300075A SI 9300075 A SI9300075 A SI 9300075A SI 9300075 A SI9300075 A SI 9300075A
Authority
SI
Slovenia
Prior art keywords
general formula
tetrazol
pharmaceutically acceptable
hydrogen
alkyl
Prior art date
Application number
SI19939300075A
Other languages
English (en)
Slovenian (sl)
Inventor
Istvan Hermecz
Judit Sipos
Lelle Vasvari-Debreczy
Zoltan Kapui
Agnes Horvath
Maria Balogh
Geza Kereszturi
Kinga Boer
Aniko Pajor
Original Assignee
Chinoin Gyogyszer-
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer- filed Critical Chinoin Gyogyszer-
Publication of SI9300075A publication Critical patent/SI9300075A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI19939300075A 1992-02-13 1993-02-12 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2a)pyrimidin-4-ones, pharmaceutical preparations comprising the same and process pro their preparing SI9300075A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9200432A HUT64064A (en) 1992-02-13 1992-02-13 Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient

Publications (1)

Publication Number Publication Date
SI9300075A true SI9300075A (en) 1993-09-30

Family

ID=10981335

Family Applications (1)

Application Number Title Priority Date Filing Date
SI19939300075A SI9300075A (en) 1992-02-13 1993-02-12 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2a)pyrimidin-4-ones, pharmaceutical preparations comprising the same and process pro their preparing

Country Status (7)

Country Link
CN (1) CN1080289A (zh)
AU (1) AU3573793A (zh)
HU (1) HUT64064A (zh)
IL (1) IL104706A0 (zh)
MX (1) MX9300779A (zh)
SI (1) SI9300075A (zh)
WO (1) WO1993016076A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
ITMI20011764A1 (it) * 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
MXPA05003607A (es) * 2002-10-04 2005-11-17 Prana Biotechnology Ltd Compuestos neurologicamente activos.
EP1818058A3 (en) * 2006-02-13 2007-11-07 Astion Pharma A/S Treatment of mmp-mediated dermatological diseases with pemirolast
WO2007093184A2 (en) * 2006-02-13 2007-08-23 Astion Pharma A/S Treatment of mmp-mediated dermatological diseases with pemirolast
SI2448938T1 (sl) 2009-06-29 2014-08-29 Incyte Corporation Experimental Station Pirimidinoni kot zaviralci pi3k
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
US9193721B2 (en) 2010-04-14 2015-11-24 Incyte Holdings Corporation Fused derivatives as PI3Kδ inhibitors
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
JP5961187B2 (ja) 2010-12-20 2016-08-02 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｐｉ３ｋ阻害剤としてのｎ−（１−（置換フェニル）エチル）−９ｈ−プリン−６−アミン
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
CA2846652C (en) 2011-09-02 2019-11-05 Incyte Corporation Heterocyclylamines as pi3k inhibitors
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
ES2843522T3 (es) 2015-02-27 2021-07-19 Incyte Corp Sales del inhibidor de PI3K y procesos para su preparación
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044796C (en) * 1990-06-21 2001-10-16 Atsunori Sano Process for producing pyrido[1,2-a] pyrimidine derivative

Also Published As

Publication number Publication date
CN1080289A (zh) 1994-01-05
WO1993016076A1 (en) 1993-08-19
HUT64064A (en) 1993-11-29
MX9300779A (es) 1993-09-30
IL104706A0 (en) 1993-06-10
AU3573793A (en) 1993-09-03
HU9200432D0 (en) 1992-04-28

Similar Documents

Publication Publication Date Title
SI9300075A (en) 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2a)pyrimidin-4-ones, pharmaceutical preparations comprising the same and process pro their preparing
US3700673A (en) 3-4-dihydrobenzo(b) (1,7)naphthyridin-1(2h)-ones
JP2001520645A (ja) 新規な化合物
WO1996035689A1 (en) Novel deazapurine derivatives; a new class of crf1 specific ligands
US3920652A (en) Aromatic substituted pyrazola {8 1,5a{9 {0 pyrimidine compounds useful as xanthine oxidase inhibitors
US3993656A (en) 1,8-Naphthyridine compounds
EP0119774B1 (en) Anti-inflammatory pyrazolo pyridines
SU999972A3 (ru) Способ получени производных пиридо-(1,2-а) пиримидина или их фармацевтически приемлемых солей,или их оптически активных изомеров
PL89008B1 (zh)
US4053474A (en) Pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidine
SU893134A3 (ru) Способ получени имидазо-2,1-8-тиазолин-или-тиазин-производных в виде смеси или отдельных изомеров или их кислотно-аддитивных солей
FI62085C (fi) Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-oxo-1,6,7,8-tetrahydro-4h-pyrido-(1,2-a)-pyrimidinderivat
US5728691A (en) Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
JPS61183286A (ja) ２‐アルコキシ‐ｎ‐（１‐アザビシクロ〔２，２，２〕オクタン‐３‐イル）アミノベンズアミドの製法
US3992380A (en) 5,8-Dihydro-5-oxo-2-(4-or 3-pyridinyl)pyrido[2,3-d]pyrimidine-6-carboxylic acids and esters
CA1173445A (en) Quinolone derivatives and their use as pharmaceuticals
US5334718A (en) Chemical process and intermediates used therein
JP2899757B2 (ja) ジヒドロイミダゾキノリノンオキシムスルホン酸誘導体
US4048184A (en) 6-Phenyl-2H-pyrazolo[3,4-b]pyridines
JPH0516437B2 (zh)
PL123812B1 (en) Process for preparing novel derivatives of pyran-4-one
EP0046990A2 (en) 2-Halogeno-4-alkyl-4,7-dihydro-7-oxo-thieno(3,2-b)-pyridine-6-carboxylic acids, salts thereof at the carboxyl group, pharmaceutical use thereof, and intermediates thereof
CA1049017A (en) Pyrrolo (3,4-b) pyridines and methods for their preparation
JPS6029716B2 (ja) １，４‐オキサチイノ〔２，３‐ｃ〕ピロール誘導体の製造法
US3324003A (en) Method of controlling growth of bacteria using 4-methyl-1-benzo[f]quinolone-2-carboxylic acid